Search results
Depression rates have fallen since the pandemic—but some groups report more frequent symptoms
Stacker via AOL· 9 hours agoDepression has lingered at elevated levels... of depression taper off even more as Americans clear...
Moderna Stock Rebounds From Its RSV Vaccine Fallout — Is It A Buy, Again?
Investor's Business Daily· 6 days agoMetabolic decompensation is a series of symptoms that includes vomiting and food refusal. So, Is...
Asthma, COPD often not diagnosed, study indicates
UPI· 1 day agoFinding and treating people with undiagnosed asthma or chronic obstructive pulmonary disease improved their health and led to fewer appointments for...
Long Dismissed, Chronic Lyme Is Finally in the Spotlight
Time Magazine· 4 days agoSue Gray, 59, has been sick half her life. When Gray was 30 and living with her then-husband in the...
Does Medicare Cover the RSV Vaccine?
US News Health· 7 days agoCDC recommends vaccination for higher-risk populations. Two vaccines – Arexvy and Abrysvo – are currently approved by the FDA for those ages 60 and older and offers protection ...
NEW DATA PRESENTED AT ATS 2024 SHOW THE POTENTIAL OF TEZSPIRE® TO HELP PATIENTS LIVING WITH COPD
The Pilot News· 1 day agoAmgen (NASDAQ:AMGN) and AstraZeneca today announced the results of the Phase 2a COURSE trial evaluating Tezspire® (tezepelumab-ekko) in people with moderate to very severe chronic obstructive ...
Press Release: Dupixent® late-breaking data from NOTUS confirmatory phase 3 COPD study presented at...
Benzinga· 9 hours agoDupixent® late-breaking data from NOTUS confirmatory phase 3 COPD study presented at ATS and published in NEJM NOTUS results confirm landmark data from the phase 3 BOREAS study and show Dupixent significantly
Critics Say FDA's Use of Surrogate Markers Falling Short
Medscape· 4 days agoAs the FDA's use of surrogate endpoints in the drug approval process is increasing, researchers are...
Investigational Seladelpar Demonstrates Significant Improvements in Liver Disease Progression and...
Morningstar· 3 days agoInvestigational Seladelpar Demonstrates Significant Improvements in Liver Disease Progression and Reduced Itching in Primary Biliary Cholangitis - 70% of Patients Receiving Seladelpar 10mg Achieved the Clinically Meaningful Composite Endpoint and 37
Rural, Hispanic communities among those most benefited by telehealth
Olean Times Herald· 4 days agoTelehealth is now an essential element in our health care system, ensuring that patients can see a...